| vesicle mediated transport | GO:0016192 | 381 | 0.327 | |
| striated muscle myosin thick filament assembly | GO:0071688 | 3 | 0.307 | |
| cellular macromolecular complex assembly | GO:0034622 | 153 | 0.273 | |
| rrna processing | GO:0006364 | 3 | 0.142 | |
| regulation of cellular component biogenesis | GO:0044087 | 201 | 0.137 | |
| sex differentiation | GO:0007548 | 81 | 0.125 | |
| dna templated transcription elongation | GO:0006354 | 18 | 0.124 | |
| actin cytoskeleton organization | GO:0030036 | 206 | 0.122 | |
| reproductive system development | GO:0061458 | 74 | 0.114 | |
| endocytosis | GO:0006897 | 310 | 0.101 | |
| intracellular transport | GO:0046907 | 228 | 0.099 | |
| muscle cell differentiation | GO:0042692 | 103 | 0.078 | |
| phosphorylation | GO:0016310 | 294 | 0.075 | |
| rna processing | GO:0006396 | 147 | 0.074 | |
| protein polymerization | GO:0051258 | 42 | 0.070 | |
| g2 dna damage checkpoint | GO:0031572 | 69 | 0.068 | |
| multi multicellular organism process | GO:0044706 | 123 | 0.068 | |
| mitotic dna damage checkpoint | GO:0044773 | 74 | 0.067 | |
| regulation of intracellular signal transduction | GO:1902531 | 236 | 0.067 | |
| positive regulation of rna metabolic process | GO:0051254 | 271 | 0.066 | |
| gonad development | GO:0008406 | 50 | 0.066 | |
| reproductive structure development | GO:0048608 | 74 | 0.063 | |
| developmental growth | GO:0048589 | 280 | 0.062 | |
| cellular component assembly involved in morphogenesis | GO:0010927 | 151 | 0.061 | |
| protein complex biogenesis | GO:0070271 | 201 | 0.061 | |
| positive regulation of phosphate metabolic process | GO:0045937 | 139 | 0.057 | |
| body morphogenesis | GO:0010171 | 2 | 0.055 | |
| oviposition | GO:0018991 | 19 | 0.052 | |
| multi organism behavior | GO:0051705 | 175 | 0.050 | |
| positive regulation of nitrogen compound metabolic process | GO:0051173 | 354 | 0.049 | |
| development of primary sexual characteristics | GO:0045137 | 50 | 0.049 | |
| positive regulation of cellular component biogenesis | GO:0044089 | 80 | 0.049 | |
| phagocytosis | GO:0006909 | 215 | 0.048 | |
| positive regulation of phosphorus metabolic process | GO:0010562 | 139 | 0.048 | |
| regulation of cytoskeleton organization | GO:0051493 | 89 | 0.047 | |
| wnt signaling pathway | GO:0016055 | 98 | 0.047 | |
| regulation of cell cycle process | GO:0010564 | 181 | 0.046 | |
| cellular response to dna damage stimulus | GO:0006974 | 223 | 0.045 | |
| larval development | GO:0002164 | 104 | 0.045 | |
| protein modification process | GO:0036211 | 438 | 0.045 | |
| rna interference | GO:0016246 | 27 | 0.045 | |
| small gtpase mediated signal transduction | GO:0007264 | 88 | 0.043 | |
| regulation of meiosis | GO:0040020 | 3 | 0.042 | |
| actomyosin structure organization | GO:0031032 | 56 | 0.042 | |
| intracellular signal transduction | GO:0035556 | 300 | 0.042 | |
| myofibril assembly | GO:0030239 | 36 | 0.041 | |
| macromolecular complex assembly | GO:0065003 | 256 | 0.041 | |
| regulation of transcription elongation from rna polymerase ii promoter | GO:0034243 | 15 | 0.040 | |
| protein complex assembly | GO:0006461 | 200 | 0.040 | |
| mitotic g2 m transition checkpoint | GO:0044818 | 70 | 0.039 | |
| rna splicing | GO:0008380 | 83 | 0.039 | |
| centrosome cycle | GO:0007098 | 137 | 0.038 | |
| regulation of dna templated transcription elongation | GO:0032784 | 17 | 0.038 | |
| meiotic cell cycle | GO:0051321 | 171 | 0.038 | |
| regulation of protein complex assembly | GO:0043254 | 42 | 0.037 | |
| establishment of localization in cell | GO:0051649 | 402 | 0.037 | |
| positive regulation of protein complex assembly | GO:0031334 | 22 | 0.037 | |
| cell cycle phase transition | GO:0044770 | 140 | 0.036 | |
| actin filament based process | GO:0030029 | 220 | 0.036 | |
| regulation of mitotic cell cycle phase transition | GO:1901990 | 130 | 0.035 | |
| regulation of rna splicing | GO:0043484 | 69 | 0.035 | |
| regulation of phosphorus metabolic process | GO:0051174 | 210 | 0.035 | |
| cytoplasmic transport | GO:0016482 | 130 | 0.035 | |
| positive regulation of dna endoreduplication | GO:0032877 | 4 | 0.034 | |
| negative regulation of cell cycle phase transition | GO:1901988 | 103 | 0.033 | |
| positive regulation of signaling | GO:0023056 | 243 | 0.033 | |
| transcription elongation from rna polymerase ii promoter | GO:0006368 | 18 | 0.033 | |
| organic substance transport | GO:0071702 | 257 | 0.033 | |
| organic cyclic compound catabolic process | GO:1901361 | 168 | 0.032 | |
| cellular protein complex assembly | GO:0043623 | 71 | 0.031 | |
| ribonucleoprotein complex biogenesis | GO:0022613 | 31 | 0.030 | |
| apoptotic process | GO:0006915 | 159 | 0.029 | |
| mrna splicing via spliceosome | GO:0000398 | 73 | 0.029 | |
| dna integrity checkpoint | GO:0031570 | 81 | 0.028 | |
| regulation of developmental growth | GO:0048638 | 174 | 0.028 | |
| regulation of phosphate metabolic process | GO:0019220 | 210 | 0.028 | |
| regulation of neuron differentiation | GO:0045664 | 103 | 0.028 | |
| mitotic g2 dna damage checkpoint | GO:0007095 | 69 | 0.028 | |
| multi organism reproductive behavior | GO:0044705 | 121 | 0.028 | |
| mrna cis splicing via spliceosome | GO:0045292 | 1 | 0.027 | |
| posttranscriptional gene silencing by rna | GO:0035194 | 45 | 0.027 | |
| reproductive behavior | GO:0019098 | 122 | 0.026 | |
| regulation of catalytic activity | GO:0050790 | 185 | 0.025 | |
| hematopoietic progenitor cell differentiation | GO:0002244 | 1 | 0.025 | |
| regulation of protein polymerization | GO:0032271 | 28 | 0.024 | |
| positive regulation of signal transduction | GO:0009967 | 223 | 0.024 | |
| regulation of protein stability | GO:0031647 | 43 | 0.024 | |
| positive regulation of gene expression | GO:0010628 | 290 | 0.024 | |
| ras protein signal transduction | GO:0007265 | 88 | 0.024 | |
| mitotic cell cycle phase transition | GO:0044772 | 138 | 0.024 | |
| organonitrogen compound metabolic process | GO:1901564 | 318 | 0.024 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 108 | 0.024 | |
| rna splicing via transesterification reactions with bulged adenosine as nucleophile | GO:0000377 | 73 | 0.023 | |
| spindle organization | GO:0007051 | 253 | 0.023 | |
| glial cell migration | GO:0008347 | 31 | 0.023 | |
| gene silencing by rna | GO:0031047 | 57 | 0.023 | |
| stem cell differentiation | GO:0048863 | 117 | 0.023 | |
| eye development | GO:0001654 | 323 | 0.022 | |
| regulation of mrna splicing via spliceosome | GO:0048024 | 64 | 0.022 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 145 | 0.022 | |
| cell proliferation | GO:0008283 | 299 | 0.021 | |
| hematopoietic or lymphoid organ development | GO:0048534 | 57 | 0.021 | |
| positive regulation of macromolecule metabolic process | GO:0010604 | 405 | 0.021 | |
| positive regulation of response to stimulus | GO:0048584 | 323 | 0.021 | |
| regulation of cell cycle | GO:0051726 | 291 | 0.021 | |
| imaginal disc derived appendage morphogenesis | GO:0035114 | 395 | 0.021 | |
| negative regulation of mitotic cell cycle phase transition | GO:1901991 | 103 | 0.020 | |
| purine ribonucleoside metabolic process | GO:0046128 | 127 | 0.020 | |
| regulation of phosphorylation | GO:0042325 | 147 | 0.020 | |
| mitotic dna integrity checkpoint | GO:0044774 | 75 | 0.019 | |
| aromatic compound catabolic process | GO:0019439 | 166 | 0.019 | |
| negative regulation of cytoskeleton organization | GO:0051494 | 30 | 0.019 | |
| rna splicing via transesterification reactions | GO:0000375 | 73 | 0.019 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 165 | 0.018 | |
| regulation of molecular function | GO:0065009 | 217 | 0.018 | |
| striated muscle cell differentiation | GO:0051146 | 90 | 0.018 | |
| signal transduction by phosphorylation | GO:0023014 | 107 | 0.018 | |
| positive regulation of transcription from rna polymerase ii promoter | GO:0045944 | 204 | 0.018 | |
| meiotic nuclear division | GO:0007126 | 151 | 0.017 | |
| regulation of neurogenesis | GO:0050767 | 158 | 0.017 | |
| regulation of cell differentiation | GO:0045595 | 302 | 0.017 | |
| cell division | GO:0051301 | 248 | 0.016 | |
| mapk cascade | GO:0000165 | 107 | 0.016 | |
| purine nucleoside metabolic process | GO:0042278 | 127 | 0.016 | |
| ribonucleoprotein complex subunit organization | GO:0071826 | 28 | 0.016 | |
| defense response | GO:0006952 | 300 | 0.016 | |
| regulation of wnt signaling pathway | GO:0030111 | 68 | 0.016 | |
| protein phosphorylation | GO:0006468 | 169 | 0.015 | |
| positive regulation of biosynthetic process | GO:0009891 | 316 | 0.015 | |
| regulation of mrna metabolic process | GO:1903311 | 72 | 0.015 | |
| regulation of localization | GO:0032879 | 275 | 0.015 | |
| striated muscle cell development | GO:0055002 | 50 | 0.015 | |
| embryo development ending in birth or egg hatching | GO:0009792 | 152 | 0.014 | |
| positive regulation of developmental growth | GO:0048639 | 62 | 0.014 | |
| immune system development | GO:0002520 | 57 | 0.014 | |
| centrosome organization | GO:0051297 | 163 | 0.014 | |
| positive regulation of phosphorylation | GO:0042327 | 87 | 0.013 | |
| positive regulation of cell communication | GO:0010647 | 250 | 0.013 | |
| negative regulation of apoptotic process | GO:0043066 | 63 | 0.013 | |
| photoreceptor cell differentiation | GO:0046530 | 170 | 0.013 | |
| nucleobase containing compound transport | GO:0015931 | 56 | 0.013 | |
| regulation of cell cycle phase transition | GO:1901987 | 130 | 0.013 | |
| muscle cell development | GO:0055001 | 50 | 0.013 | |
| ribonucleotide metabolic process | GO:0009259 | 145 | 0.013 | |
| chromatin remodeling | GO:0006338 | 72 | 0.013 | |
| positive regulation of nucleobase containing compound metabolic process | GO:0045935 | 332 | 0.013 | |
| molting cycle | GO:0042303 | 56 | 0.013 | |
| alternative mrna splicing via spliceosome | GO:0000380 | 60 | 0.013 | |
| chromatin organization | GO:0006325 | 207 | 0.012 | |
| nucleotide catabolic process | GO:0009166 | 109 | 0.012 | |
| positive regulation of cell cycle | GO:0045787 | 43 | 0.012 | |
| ribonucleotide catabolic process | GO:0009261 | 109 | 0.012 | |
| positive regulation of mrna processing | GO:0050685 | 4 | 0.012 | |
| myosin filament assembly | GO:0031034 | 5 | 0.012 | |
| purine nucleotide catabolic process | GO:0006195 | 109 | 0.012 | |
| response to external biotic stimulus | GO:0043207 | 293 | 0.011 | |
| synapse organization | GO:0050808 | 196 | 0.011 | |
| transcription initiation from rna polymerase ii promoter | GO:0006367 | 25 | 0.011 | |
| positive regulation of protein polymerization | GO:0032273 | 14 | 0.011 | |
| stem cell maintenance | GO:0019827 | 67 | 0.011 | |
| regulation of meiotic cell cycle | GO:0051445 | 9 | 0.011 | |
| positive regulation of macromolecule biosynthetic process | GO:0010557 | 283 | 0.011 | |
| myosin filament organization | GO:0031033 | 5 | 0.011 | |
| heterocycle catabolic process | GO:0046700 | 166 | 0.011 | |
| cell cycle checkpoint | GO:0000075 | 95 | 0.011 | |
| positive regulation of cellular biosynthetic process | GO:0031328 | 316 | 0.011 | |
| actin polymerization or depolymerization | GO:0008154 | 31 | 0.011 | |
| negative regulation of gene expression | GO:0010629 | 387 | 0.010 | |
| purine ribonucleotide catabolic process | GO:0009154 | 109 | 0.010 | |
| cell death | GO:0008219 | 279 | 0.010 | |
| nitric oxide metabolic process | GO:0046209 | 1 | 0.010 | |
| negative regulation of cell cycle process | GO:0010948 | 109 | 0.010 | |
